Results 21 to 30 of about 23,541 (260)

Microwave ablation versus parathyroidectomy for severe secondary hyperparathyroidism in patients on hemodialysis: a retrospective multicenter study

open access: yesInternational Journal of Hyperthermia, 2021
Background Microwave ablation is effective for severe secondary hyperparathyroidism, but the difference in efficacy between microwave ablation and parathyroidectomy remains unclear.
Zongli Diao   +8 more
doaj   +1 more source

Controversy and progress in parathyroidectomy for the treatment of secondary hyperparathyroidism [PDF]

open access: yesWaike lilun yu shijian, 2023
Secondary hyperparathyroidism is one of common complications of long-term dialysis patients. Although medical treatment schemes such as calcimimetics and vitamin D analogues can be selected, patients refractory to drug treatment can still refer to ...
WANG Qiang, ZHA Siluo, ZHANG Wei
doaj   +1 more source

Cinacalcet: the chemical parathyroidectomy? [PDF]

open access: yesClinical Kidney Journal, 2013
The existing body of evidence suggests that cinacalcet isan effective drug for secondary hyperparathyroidism(SHPT) control in patients undergoing maintenance dialy-sis (CKD-5D) [1–10]. Indeed, available evidence suggeststhat by modulating the parathyroid calcium-sensing re-ceptor affinity to serum calcium, cinacalcet lowers by40–50% (250–350 pg/mL ...
A. Bellasi, M. Cozzolino
openaire   +4 more sources

Parathyroidectomy after kidney transplantation: short-and long-term impact on renal function

open access: yesClinics, 2011
INTRODUCTION: Kidney transplantation corrects endocrine imbalances. Nevertheless, these early favorable events are not always followed by rapid normalization of parathyroid hormone secretion.
Gustavo Fernandes Ferreira   +5 more
doaj   +1 more source

Parathyroidectomy versus cinacalcet in the treatment of tertiary hyperparathyroidism after kidney transplantation: a retrospective study [PDF]

open access: yesKidney Research and Clinical Practice, 2022
Background Hyperparathyroidism is common in patients with chronic kidney disease with reduced renal function and has been observed after kidney transplantation.
Suyun Jung   +10 more
doaj   +1 more source

Lack of evidence does not justify neglect. how can we address unmet medical needs in calciphylaxis [PDF]

open access: yes, 2016
Calcific uraemic arteriolopathy (CUA), or calciphylaxis, is a rare disease predominantly occurring in comorbidity with dialysis. Due to the very low frequency of CUA, prospective studies on its management are lacking and even anecdotal reports on ...
Brandenburg, Vincent Matthias   +14 more
core   +1 more source

Calciphylaxis following kidney transplantation: a case report [PDF]

open access: yes, 2009
Introduction: Calciphylaxis occurring after kidney transplantation is rare and rarely reported. It results in chronic non-healing wounds and is associated with a poor prognosis and is often fatal.
Andrew R Ready   +15 more
core   +4 more sources

A comparison of surgical treatments for tertiary hyperparathyroidism. A systematic review [PDF]

open access: yesFolia Medica
Introduction: Tertiary hyperparathyroidism develops in patients who have secondary hyperparathyroidism that persists despite successful kidney transplantation or in patients who are on chronic dialysis.
Panagoula Oikonomou   +5 more
doaj   +3 more sources

Hungry bone syndrome in peritoneal dialysis patients after parathyroid surgery

open access: yesEndocrine Connections, 2023
Secondary hyperparathyroidism (SHPT) is a common complication of end-stage kidney disease (ESKD). Hungry bone syndrome (HBS) occurs frequently in patients on maintenance dialysis receiving parathyroidectomy for refractory SHPT.
Heng Yeh   +10 more
doaj   +1 more source

Parathyroidectomy: Whom and when? [PDF]

open access: yesKidney International, 2003
Hyperparathyroidism (HPT) is common in patients on dialysis, and parathyroidectomy (PTx) is often required. We present a retrospective, descriptive analysis of data corresponding to 148 patients on dialysis undergoing PTx due to severe refractory HPT (PTH 1401 +/- 497 pg/mL, Ca 10.6 +/- 0.8 mg/dL, P 6.9 +/- 1.7 mg/dL).
Javier Menárguez   +9 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy